Navigation Links
A Trojan horse in the fight against HIV/AIDS
Date:11/7/2011

Montreal, Quebec, Canada The Centre de recherche du Centre hospitalier de l'Universit de Montral (CRCHUM) announced today that one of its researchers will receive funding of 100,000 US $ through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. Dr. Andrs Finzi will pursue an innovative global health research project, titled "Reverse Fusion: a new approach to eradicate HIV/AIDS" to deliver toxic genes to HIV-infected cells and eliminate them.

Grand Challenges Explorations funds scientists and researchers worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Dr. Finzi's project is one of 110 applications Grand Challenges Explorations grants that was selected among more than 2,000 applications, announced today.

"We believe in the power of innovationthat a single bold idea can pioneer solutions to our greatest health and development challenges," said Chris Wilson, Director of Global Health Discovery for the Bill & Melinda Gates Foundation. "Grand Challenges Explorations seeks to identify and fund these new ideas wherever they come from, allowing scientists, innovators and entrepreneurs to pursue the kinds of creative ideas and novel approaches that could help to accelerate the end of polio, cure HIV infection or improve sanitation."

Projects that are receiving funding show promise in tackling priority global health issues where solutions do not yet exist. This includes finding effective methods to eliminate or control infectious diseases such as polio and HIV as well as discovering new sanitation technologies.
'/>"/>

Contact: Nathalie Forgue
nathalie.forgue.chum@ssss.gouv.qc.ca
514-890-8000 x15262
Centre hospitalier de l'Universit de Montral
Source:Eurekalert

Page: 1

Related biology news :

1. Sleeping Trojan horse to aid imaging of diseased cells
2. Trojan Horse ploy to sneak protective drug into brains of stroke patients
3. Trojan Horse attack on native lupine
4. Light dependency underlies beneficial jetlag in racehorses
5. Endangered horse has ancient origins and high genetic diversity, new study finds
6. Research bolsters importance of horseshoe crab spawning for migrating shorebirds
7. Scientists learn how horseweed shrugs off herbicide
8. Sardines and horse mackerel identified using forensic techniques
9. Horse blind date could lead to loss of foal
10. Canadian researchers first worldwide to generate pluripotent stem cells from horses
11. Climate change affects horseshoe crab numbers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology: